Sodium acetate-mediated inhibition of histone deacetylase alleviates hepatic lipid dysregulation and its accompanied injury in streptozotocin-nicotinamide-induced diabetic rats

Sarwar, 2010, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration, Lancet, 375, 2215, 10.1016/S0140-6736(10)60484-9 Guariguata, 2014, Global estimates of diabetes prevalence for 2013 and projections for 2035, Diabetes Res. Clin. Pract., 103, 137, 10.1016/j.diabres.2013.11.002 Kashanian, 2015, Non-alcoholic fatty liver disease in patients with diabetes mellitus: a clinician’s perspective, Int. J. Digest. Dis., 1, 10 Tolman, 2007, Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease, Diabetes Care, 30, 734, 10.2337/dc06-1539 Mantovani, 2017, Nonalcoholic fatty liver disease (NAFLD) and risk of cardiac arrhythmias: a new aspect of the liver-heart axis, J. Clin. Transl. Hepatol., 5, 134 Mohamed, 2016, Mechanisms of diabetes-induced liver damage: the role of oxidative stress and inflammation, Sultan Qaboos Univ. Med. J., 16, e132, 10.18295/squmj.2016.16.02.002 Zhao, 2019, Management of diabetes mellitus in patients with chronic liver diseases, J. Diabetes Res., 10.1155/2019/6430486 Romagnoli, 2010, Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats, Free Radic. Biol. Med., 49, 171, 10.1016/j.freeradbiomed.2010.03.024 Reid, 2006, Non-alcoholic fatty liver disease, 1772 Crawford, 2009, Liver and biliary tract, 833 Byrne, 2015, NAFLD: a multisystem disease, J. Hepatol., 62, S47, 10.1016/j.jhep.2014.12.012 Mercado, 2002, Genetics of insulin resistance, Curr. Diab. Rep., 2, 83, 10.1007/s11892-002-0063-9 Scheen, 2005, Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion, Diabetes Metab., 31, S27 Asrih, 2013, Emerging role of epigenetics and miRNA in diabetic cardiomyopathy, Cardiovasc. Pathol., 22, 117, 10.1016/j.carpath.2012.07.004 Tian, 2013, Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease, Semin. Cancer Biol., 23, 471, 10.1016/j.semcancer.2013.08.010 Del Campo, 2018, Role of inflammatory response in liver diseases: therapeutic strategies, World J. Hepatol., 10, 1, 10.4254/wjh.v10.i1.1 Xiang, 2004, Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24, Diabetes, 53, 228, 10.2337/diabetes.53.1.228 González Hernández, 2019, The short-chain fatty acid acetate in body weight control and insulin sensitivity, Nutrients, 11, 1943, 10.3390/nu11081943 Macfarlane, 2012, Bacteria, colonic fermentation, and gastrointestinal health, J. AOAC Int., 95, 50, 10.5740/jaoacint.SGE_Macfarlane Fernandes, 2014, Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans, Nutr. Diabetes, 4, e121, 10.1038/nutd.2014.23 Maslowski, 2009, Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43, Nature, 461, 1282, 10.1038/nature08530 Karlsson, 2013, Gut metagenome in European women with normal, impaired and diabetic glucose control, Nature, 498, 99, 10.1038/nature12198 Marino, 2017, Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes, Nat. Immunol., 18, 552, 10.1038/ni.3713 Kim, 2018, Microbiota or short-chain fatty acids: which regulates diabetes?, Cell. Mol. Immunol., 15, 88, 10.1038/cmi.2017.57 Lim, 2016, Vinegar as a functional ingredient to improve postprandial glycemic control—human intervention findings and molecular mechanisms, Mol. Nutr. Food Res., 60, 1837, 10.1002/mnfr.201600121 Bartolomaeus, 2019, Short-chain fatty acid propionate protects from hypertensive cardiovascular damage, Circ, 139, 1407, 10.1161/CIRCULATIONAHA.118.036652 Katz, 2000, Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans, J. Clin. Endocrinol. Metab., 85, 2402, 10.1210/jcem.85.7.6661 Mather, 2009, Surrogate measures of insulin resistance: of rats, mice, and men, Am. J. Physiol. Endocrinol. Metab., 296, E398, 10.1152/ajpendo.90889.2008 Olaniyi, 2019, Glutamine confers renoprotection by normalizing lipid and glutathione content in insulin-resistant pregnant rats, Chem. Biol. Interact., 310, 10.1016/j.cbi.2019.06.034 Miller, 2016, Systemic metabolic derangement, pulmonary effects, and insulin insufficiency following subchronic ozone exposure in rats, Toxicol. Appl. Pharmacol., 306, 47, 10.1016/j.taap.2016.06.027 Paul, 2017, Global loss of acetylcholinesterase activity with mitochondrial complexes inhibition and inflammation in brain of hypercholesterolemic mice, Sci. Rep., 7, 1, 10.1038/s41598-017-17911-z Rahman, 2007, Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method, Nat. Protoc., 1, 3159, 10.1038/nprot.2006.378 Uchiyama, 1978, Determination of malondialdehyde precursor in tissues by thiobarbituric acid, Ann. Biochem., 86, 271, 10.1016/0003-2697(78)90342-1 Phillip, 1995, Designing a coupled assay system for aspartate aminotransferase, Biochem. Educ., 23, 40, 10.1016/0307-4412(94)00116-7 Young, 2001 Kharroubi, 2015, Diabetes mellitus: the epidemic of the century, World J. Diabetes, 6, 850, 10.4239/wjd.v6.i6.850 Olaniyi, 2019, Inhibition of pyruvate dehydrogenase kinase-4 by l-glutamine protects pregnant rats against fructose-induced obesity and hepatic lipid accumulation, Biomed. Pharmacother., 110, 59, 10.1016/j.biopha.2018.11.038 Masiello, 1998, Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide, Diabetes, 47, 224, 10.2337/diab.47.2.224 Ghasemi, 2014, Streptozotocin-nicotinamide-induced rat model of type 2 diabetes, Acta Physiol. Hung., 101, 408, 10.1556/APhysiol.101.2014.4.2 Lin, 2010, Current views on type 2 diabetes, J. Endocrinol., 204, 1, 10.1677/JOE-09-0260 Hegazy, 2019, Diabetes mellitus, nonalcoholic fatty liver disease, and conjugated linoleic acid (Omega 6): what is the link?, J. Diabetes Res., 10.1155/2019/5267025 Bojsen-Møller, 2018, Hepatic insulin clearance in regulation of systemic insulin concentrations—role of carbohydrate and energy availability, Diabetes, 67, 2129, 10.2337/db18-0539 Browning, 2004, Molecular mediators of hepatic steatosis and liver injury, J. Clin. Invest., 114, 147, 10.1172/JCI200422422 Hegazy, 2019, Diabetes mellitus, nonalcoholic fatty liver disease, and conjugated linoleic acid (Omega 6): what is the link?, J. Diabetes Res., 10.1155/2019/5267025 Chen, 2017, A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease, Lipids Health Dis., 16, 203, 10.1186/s12944-017-0572-9 Sanyal, 2015, Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes, Indian J. Endocrinol. Metab., 19, 597, 10.4103/2230-8210.163172 Petta, 2014, Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease, PLoS One, 9, 10.1371/journal.pone.0087523 Zhang, 2017, Role of histone deacetylase expression levels and activity in the inflammatory responses of patients with chronic hepatitis B, Mol. Med. Rep., 15, 2744, 10.3892/mmr.2017.6290